Best 3 Growth Stocks to Watch Now

Investing.com -- Growth investors searching for stocks with explosive earnings potential have several compelling options according to recent WarrenAI rankings. These three companies stand out for their extraordinary projected EPS growth rates and attractive valuations relative to their growth prospects.

Okta Inc (NASDAQ:OKTA), the identity management leader, tops the list with remarkable growth metrics. The company is projected to deliver an astonishing 6,077.7% EPS growth by fiscal year 2026 as it transitions firmly into profitability. Trading at $89.45, Okta offers 16.4% upside to its fair value estimate, while analysts are even more bullish with a mean target of $120.56 and high estimates reaching $142.

With a forward P/E of 25x and a minuscule PEG ratio of 0.01, Okta presents a rare combination of rapid growth at a reasonable price. Technical indicators show "Strong Buy" signals on short-term charts, and the company maintains good financial health with approximately $750 million in operating cash flow.

Okta announced new platform capabilities designed to secure AI agents at its Oktane user conference. Following the event, several firms including Stifel, Truist Securities, and DA Davidson reiterated their Buy ratings on the company.

LandBridge Co LLC (NYSE:LB) secures the second position as a small-cap growth rocket. The company boasts projected EPS growth of 6,745.6% for fiscal year 2025 alongside impressive revenue growth of 77.3%. At $56.60 per share, LandBridge trades 22.5% below its fair value estimate, with analyst targets averaging $69.88.

The stock’s incredibly low PEG ratio of 0.0046 suggests deep value despite its hyper-growth profile. Technical indicators unanimously signal "Strong Buy" across all short-term timeframes, though investors should note the negative year-to-date return indicating higher volatility. While LandBridge carries moderate debt with a debt-to-equity ratio of 87.4%, its overall financial health score remains "Great" according to WarrenAI’s assessment.

In recent news, LandBridge Co LLC reported that its second-quarter revenue grew 83% year-over-year to $47.5 million, with an EPS of $0.24. The company also entered into a strategic agreement with NRG Energy for a potential data center power project in Texas.

Incyte Corporation (NASDAQ:INCY) rounds out the top three as a biotech growth powerhouse. Trading at $87.30, Incyte offers 19.7% potential upside to fair value while projecting 4,071.7% EPS growth in fiscal year 2025. The stock’s PEG ratio of 0.0038 reflects its attractive growth-to-value proposition.

Technical indicators show consistent "Strong Buy" signals across multiple timeframes, and the company has received recent analyst upgrades, including a $115 price target from Stifel. Incyte maintains a "Great" financial health score with robust cash flows, though investors should note Oppenheimer’s recent downgrade warning that the valuation may be full after the stock’s recent run-up.

Incyte Corporation received a downgrade to Perform from Oppenheimer, while UBS and RBC Capital raised their price targets. The company also presented encouraging clinical data for two investigational cancer therapies at the European Society of Medical Oncology Congress.

These three growth stocks offer compelling combinations of projected earnings acceleration, reasonable valuations, and positive technical indicators according to WarrenAI’s comprehensive analysis.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.